AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 4/30

$0.15−0.01 (-3.59%)

Close on Nov 13, 2026Market cap $7.63MP/E –Yield –

AEON Biopharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

AEON Biopharma's total debt was $0 at Sep 30, 2023. For fiscal 2022 it was $23.13M.

Period	Period end	Value	Change
FY2022	Dec 31, 2022	$23.13M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2023	Sep 30, 2023	$0	–
Q4 FY2022	Dec 31, 2022	$23.13M	–

See a number that looks wrong?